We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience. By continuing to
use our site, you agree to the use of cookies.

ESC-HF 2016

Kristjan Karason (Sweden)

How to treat patients during deterioration of heart failure to avoid kidney dysfunction: pharmacological options (29:44 min)
ESC-HF 2016

Francesco Fedele (Italy)

How to treat patients in acute heart failure to avoid kidney dysfunction: pharmacological options (34:22 min)
ESC-HF 2016

Fabio Guarracino (Italy)

Why and how to treat patients in cardiogenic shock with inodilators (40:32 min)
 
ESC-HF 2016

Finn Gustafsson (Denmark)

Why and how to use inodilators as a bridge to transplant or assist device (28:12 min)
 

ESC-HF 2016

Robert H.G. Schwinger (Germany)

How to use inotropes in daily clinical practice (55:00 min)

Prof Follath

ESC-HF 2015

Ferenc Follath (Switzerland)

Levosimendan: a unique mechanism of action (13:42 min)

Prof Mebazaa

ESC-HF 2015

Alexandre Mebazaa (France)

Congestion: ino- or dilator? (12:02 min)

Prof Agostoni

ESC-HF 2015

Piergiuseppe Agostoni (Italy)

Exercise performance in Advanced heart failure (11:20 min)

Prof Parissis

ESC-HF 2015

John Parissis (Greece)

Levosimendan clinical use, patient quality of life (12:13 min)

Dr Andersen

Levosimendan lectures 2013

Geir Andersen (Norway)

Levosimendan - effects on the heart (15:58 min)

Prof Parissis

Levosimendan lectures 2013

John Parissis (Greece)

Levosimendan for the management of patients with acute cardiorenal syndrome (21:13 min)

Dr Landoni

Levosimendan lectures 2012

Giovanni Landoni (Italy)

The latest meta-analysis on levosimendan: cardiology and intensive care (14:07 min)

Prof Fedele

Levosimendan lectures 2011

Francesco Fedele (Italy)

Is there economical benefit in treating AHF patients with levosimendan? (14:03 min)

Prof Mebazaa

ISICEM 2015

Alexandre Mebazaa (France)

How to intepret altered liver function tests in acute heart failure (16:08 min)

 Prof Mebazaa

Levosimendan lectures 2013

Alexandre Mebazaa (France)

Hepatic dysfunction in AHF: decrease blood flow or high CVP? (23:04 min)